SoftOx Solutions AS (SOFTX) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.355x

Based on the latest financial reports, SoftOx Solutions AS (SOFTX) has a cash flow conversion efficiency ratio of -0.355x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-8.16 Million ≈ $-858.46K USD) by net assets (Nkr22.95 Million ≈ $2.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View SoftOx Solutions AS stock price for real-time trading data and today's change.

SoftOx Solutions AS - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how SoftOx Solutions AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see SoftOx Solutions AS (SOFTX) total market value for the company's overall valuation and market capitalisation.

SoftOx Solutions AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SoftOx Solutions AS ranked by their cash flow conversion efficiency. Also see SoftOx Solutions AS (SOFTX) total assets for a full breakdown of the balance sheet.

Company Cash Flow Conversion Efficiency
Desoto Resources Ltd
AU:DES
-0.226x
Ocean Vantage Holdings Bhd
KLSE:0220
-0.026x
Park Street A/S
CO:PARKST-A
-0.014x
Otto Holding AS
IS:OTTO
0.053x
Good Way Technology Co Ltd
TWO:3272
0.056x
Plus Therapeutics Inc
NASDAQ:PSTV
-0.522x
Italian-Thai Development Public Company Limited
F:NYVF
0.490x
Reka Industrial Oyj
HE:REKA
0.024x

Annual Cash Flow Conversion Efficiency for SoftOx Solutions AS (2017–2025)

The table below shows the annual cash flow conversion efficiency of SoftOx Solutions AS from 2017 to 2025. Review how financially flexible is SoftOx Solutions AS to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Nkr22.95 Million
≈ $2.42 Million
Nkr-18.87 Million
≈ $-1.99 Million
-0.822x -340.27%
2024-12-31 Nkr95.18 Million
≈ $10.02 Million
Nkr32.56 Million
≈ $3.43 Million
0.342x +6.98%
2023-12-31 Nkr2.37 Million
≈ $249.01K
Nkr756.68K
≈ $79.62K
0.320x +105.96%
2022-12-31 Nkr16.01 Million
≈ $1.68 Million
Nkr-85.94 Million
≈ $-9.04 Million
-5.369x -557.42%
2021-12-31 Nkr88.85 Million
≈ $9.35 Million
Nkr-72.56 Million
≈ $-7.64 Million
-0.817x -3.07%
2020-12-31 Nkr76.22 Million
≈ $8.02 Million
Nkr-60.39 Million
≈ $-6.35 Million
-0.792x -548.68%
2019-12-31 Nkr86.47 Million
≈ $9.10 Million
Nkr-10.56 Million
≈ $-1.11 Million
-0.122x +88.22%
2018-12-31 Nkr14.41 Million
≈ $1.52 Million
Nkr-14.94 Million
≈ $-1.57 Million
-1.037x -81.43%
2017-12-31 Nkr26.85 Million
≈ $2.83 Million
Nkr-15.34 Million
≈ $-1.61 Million
-0.571x --

About SoftOx Solutions AS

OL:SOFTX Norway Biotechnology
Market Cap
$26.42 Million
Nkr251.10 Million NOK
Market Cap Rank
#24287 Global
#225 in Norway
Share Price
Nkr0.09
Change (1 day)
-1.67%
52-Week Range
Nkr0.05 - Nkr0.16
All Time High
Nkr112.00
About

SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that anti-infective therapy for airway infections in Norway. The company develops SIS-03, a lead clinical program that is in phase 2a to treatment of chronic airway infections. It also developing pan antimicrobial pharmaceuticals targeting bacteria, viruses, yeast, spores, and fungi. SoftOx So… Read more